Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mignon L Loh

Showing results (21-30 of 297) with videos related to

Pageof 30
Sort By:
Pediatric Blood & Cancer|November 2, 2005
Inherited predispositions and hyperactive Ras in myeloid leukemogenesisJennifer O Lauchle, Benjamin S Braun, Mignon L Loh, et al.
Pediatric Blood & Cancer|March 4, 2011
Improving outcomes for high-risk ALL: translating new discoveries into clinical careStephen P Hunger, Elizabeth A Raetz, Mignon L Loh, et al.
Leukemia Research|October 29, 2008
Juvenile myelomonocytic leukemia: a report from the 2nd International JMML SymposiumRebecca J Chan, Todd Cooper, Christian P Kratz, et al.
Blood Advances|August 31, 2021
Nf1 and Sh2b3 mutations cooperate in vivo in a mouse model of juvenile myelomonocytic leukemiaCarolina E Morales, Elliot Stieglitz, Scott C Kogan, et al.
Journal of Medical Genetics|April 9, 2016
Germline <i>RRAS2</i> mutations are not associated with Noonan syndromeJohn J Ceremsak, Ariel Yu, Emilio Esquivel, et al.
Journal of the American Academy of Dermatology|January 24, 2006
Congenital leukemia cutis with subsequent development of leukemiaInga Hofmann Zhang, Lee T Zane, Benjamin S Braun, et al.
Journal of Medicinal Chemistry|August 21, 2013
Identification of cryptotanshinone as an inhibitor of oncogenic protein tyrosine phosphatase SHP2 (PTPN11)Wei Liu, Bing Yu, Gang Xu, et al.
Journal of Pediatric Hematology/Oncology|December 7, 2002
Treatment of infantile fibrosarcoma with chemotherapy and surgery: results from the Dana-Farber Cancer Institute and Children's Hospital, BostonMignon L Loh, Peter Ahn, Antonio R Perez-Atayde, et al.
Blood Advances|September 23, 2021
JMML tumor cells disrupt normal hematopoietic stem cells by imposing inflammatory stress through overproduction of IL-1βYuhan Yan, Lei Dong, Chao Chen, et al.
Blood|October 25, 2008
A retroviral mutagenesis screen reveals strong cooperation between Bcl11a overexpression and loss of the Nf1 tumor suppressor geneBin Yin, Ruud Delwel, Peter J Valk, et al.
Pageof 30

Showing results (21-30 of 297) with videos related to

Sort By:
Pageof 30
Pediatric Blood & Cancer|November 2, 2005
Inherited predispositions and hyperactive Ras in myeloid leukemogenesisJennifer O Lauchle, Benjamin S Braun, Mignon L Loh, et al.
Pediatric Blood & Cancer|March 4, 2011
Improving outcomes for high-risk ALL: translating new discoveries into clinical careStephen P Hunger, Elizabeth A Raetz, Mignon L Loh, et al.
Leukemia Research|October 29, 2008
Juvenile myelomonocytic leukemia: a report from the 2nd International JMML SymposiumRebecca J Chan, Todd Cooper, Christian P Kratz, et al.
Blood Advances|August 31, 2021
Nf1 and Sh2b3 mutations cooperate in vivo in a mouse model of juvenile myelomonocytic leukemiaCarolina E Morales, Elliot Stieglitz, Scott C Kogan, et al.
Journal of Medical Genetics|April 9, 2016
Germline <i>RRAS2</i> mutations are not associated with Noonan syndromeJohn J Ceremsak, Ariel Yu, Emilio Esquivel, et al.
Journal of the American Academy of Dermatology|January 24, 2006
Congenital leukemia cutis with subsequent development of leukemiaInga Hofmann Zhang, Lee T Zane, Benjamin S Braun, et al.
Journal of Medicinal Chemistry|August 21, 2013
Identification of cryptotanshinone as an inhibitor of oncogenic protein tyrosine phosphatase SHP2 (PTPN11)Wei Liu, Bing Yu, Gang Xu, et al.
Journal of Pediatric Hematology/Oncology|December 7, 2002
Treatment of infantile fibrosarcoma with chemotherapy and surgery: results from the Dana-Farber Cancer Institute and Children's Hospital, BostonMignon L Loh, Peter Ahn, Antonio R Perez-Atayde, et al.
Blood Advances|September 23, 2021
JMML tumor cells disrupt normal hematopoietic stem cells by imposing inflammatory stress through overproduction of IL-1βYuhan Yan, Lei Dong, Chao Chen, et al.
Blood|October 25, 2008
A retroviral mutagenesis screen reveals strong cooperation between Bcl11a overexpression and loss of the Nf1 tumor suppressor geneBin Yin, Ruud Delwel, Peter J Valk, et al.
Pageof 30